Ovarian cancer
Results
Phase 3
This trial looked at a drug called olaparib for women with ovarian cancer, fallopian tube cancer or primary peritoneal cancer. It was for women who had a change in the BRCA1 or BRCA2 .
People could join the trial between 2013 and 2015. The team published the results in 2018.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 3 September 2013
Recruitment end: 6 March 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charlie Gourley
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 22 Oct 2026
CRUK internal database number: 11331
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
